SCHEDULE 14C INFORMATION STATEMENT
                 Information Statement Pursuant to Section 14(c)
             of the Securities Exchange Act of 1934 (Amendment No. )

Check the appropriate box:
[X] Preliminary Information Statement
[_] Confidential, for use of the Commission only (as permitted by
    Rule 14c-5(d)(21))
[_] Definitive Information Statement

                      Integrated Healthcare Holdings, Inc.
                      ------------------------------------
                (Name of Registrant as Specified In Its Charter)

Payment of Filing Fee (Check the appropriate box):

[X] No fee required
[ ] Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.

     1) Title of each class of securities to which transaction applies:

     2) Aggregate number of securities to which transaction applies:

     3) Per unit price or other underlying value of transaction computed
        pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
        filing is calculated and state how it was determined.): ________

     4) Proposed maximum aggregate value of transaction: ___________

     5) Total Fee Paid: _________

[ ] Fee paid previously with preliminary materials.

[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule
    0-11(a)(2) and identify the filing for which the offsetting fee was paid
    previously. Identify the previous filing by registration statement number,
    or the Form or Schedule and the date of its filing.

     1) Amount Previously Paid: _________

     2) Form, Schedule or Registration Statement No.: _________

     3) Filing Party: _________

     4) Dated Filed: _________







                      INTEGRATED HEALTHCARE HOLDINGS, INC.
                            1301 NORTH TUSTIN AVENUE
                           SANTA ANA, CALIFORNIA 92705
                       -----------------------------------

                 NOTICE OF STOCKHOLDER ACTION BY WRITTEN CONSENT
                       -----------------------------------

December ____, 2007

       We are writing to advise you that Integrated Healthcare Holdings, Inc.
(the "Company") intends to amend and restate its Articles of Incorporation in
the form attached as Appendix A (the "Amended Articles") for the following
purposes:

       o      to increase the Company's authorized shares of Common Stock, $.001
              par value per share, from 250,000,000 to 400,000,000 shares;

       o      to provide for the indemnification and exculpation of directors of
              the Company in the Amended Articles as permitted under Nevada law;

       o      to eliminate out-dated or irrelevant provisions in the original
              Articles of Incorporation which were adopted in 1988 by the shell
              company that became Integrated Healthcare Holdings, Inc.,
              including eliminating the names and addresses of the original
              incorporators, registered agent and directors of the Company; and

       o      To consolidate in one document the original Articles of
              Incorporation of the Company and various amendments that have been
              adopted since the original Articles were filed.

       This action was approved on or about October 8, 2007 by the unanimous
written consent of our Board of Directors. In addition, stockholders holding a
majority of our outstanding shares of Common Stock approved this action by
written consent in lieu of a meeting on or about October 8, 2007, in accordance
with the relevant sections of the Nevada Revised Statutes.

       This action will not be effective until we file the Amended Articles with
the Nevada Secretary of State. We intend to file the Amended Articles 20 days
after this Information Statement is first mailed to our stockholders.

       Our primary purpose in increasing the number of authorized shares of
Common Stock is to provide sufficient authorized shares to fulfill our
obligations to issue Common Stock under agreements recently executed by the
Company in connection with the refinancing of our indebtedness and under equity
instruments previously issued by the Company. We also wish to better position
the Company to take advantage of possible future financing opportunities and
other corporate purposes, as the Board of Directors determines in its discretion
to be in the best interests of the Company.

       No action is required by you. The accompanying Information Statement is
furnished only to inform our stockholders of the action described above before
it takes effect in accordance with Rule 14c-2 promulgated under the Securities
Act of 1934. This Information Statement is being mailed to you on or about
December ___, 2007.

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.



                                        ------------------------------------
                                        Bruce Mogel
                                        Chief Executive Officer







                      INTEGRATED HEALTHCARE HOLDINGS, INC.
                       -----------------------------------

                              INFORMATION STATEMENT
                       -----------------------------------

                INFORMATION CONCERNING ACTION BY WRITTEN CONSENT

       This Information Statement is being mailed or furnished to the
stockholders of Integrated Healthcare Holdings, Inc. (the "Company") in
connection with the approval by the Company's Board of Directors on or about
October 8, 2007 of the amendment and restatement of the Articles of
Incorporation of the Company in the form attached as Appendix A (the "Amended
Articles"), and the approval on or about October 8, 2007 of the Amended Articles
by written consent of the holders of a majority of the outstanding shares of
Common Stock of the Company. Accordingly, all necessary corporate approvals in
connection with the approval of the Amended Articles have been obtained and this
Information Statement is furnished solely for the purpose of informing the
stockholders of the Company, in the manner required under the Securities
Exchange Act of 1934, as amended, of these corporate actions before they take
effect.

       This Information Statement is first being mailed or furnished to the
stockholders of record of the Company on or about December 10, 2007. The
Information Statement is being delivered only to inform you of the corporate
action described herein before it takes effect in accordance with Rule 14c-2
promulgated under the Securities Exchange Act of 1934, as amended.

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.

       The Nevada Revised Statutes require that, in order for us to amend our
Articles of Incorporation, such amendment must be approved by our Board of
Directors and approved by a majority or the outstanding shares entitled to vote
thereon. The Nevada Revised Statutes also provide than any action which may be
taken at a meeting of stockholders may be taken without a meeting and without
prior notice, if a consent in writing, setting forth the action so taken, shall
be signed by the holders of a majority of the outstanding shares entitled to
vote.

       As of October 8, 2007, there were 137,095,716 shares of our Common Stock
outstanding. Stockholders holding a total of 108,636,716 outstanding shares of
Common Stock, constituting a majority of our outstanding shares entitled to
vote, approved the Amended Articles. There will not be a meeting of stockholders
and none is required under Nevada law because this action has been approved by
written consent of the holders of a majority of outstanding shares.

       We have asked brokers and other custodians, nominees and fiduciaries to
forward this Information Statement to the beneficial owners of the Common Stock
held of record by such persons and we will reimburse such persons for
out-of-pocket expenses incurred in forwarding such material.

INTERESTS IN CERTAIN PERSONS IN MATTERS TO BE ACTED UPON

       No director, executive officer or associate of any director or executive
officer has any substantial interest, direct or indirect, by security holdings
or otherwise, in the increase in number of shares of authorized Common Stock
which is not shared by all other stockholders of the Company.

EFFECTIVE DATE OF AMENDMENT

       The amendment and restatement of our Articles of Incorporation will
become effective upon the filing, with the Nevada Secretary of State, of the
Amended Articles, a copy of which is attached hereto as Appendix A. We intend to
file the Amended Articles 20 days after this Information Statement is first
mailed to stockholders.


                                       1



INFORMATION STATEMENT COSTS

       The cost of delivering this Information Statement, including the
preparation, assembly and mailing of the Information Statement, as well as the
cost of forwarding this material to the beneficial owners of our capital stock
will be borne by us. We may reimburse brokerage firms and others for expenses in
forwarding Information Statement materials to the beneficial owners of our
capital stock.

DISSENTERS' RIGHTS

       The Nevada Revised Statutes do not provide for dissenters' right of
appraisal in connection with an increase in the authorized shares of Common
Stock.

COMMON STOCK OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

       The following table sets forth information known to us with respect to
the beneficial ownership of our Common Stock as of October 31, 2007 by:

       o      each stockholder known to us to own beneficially more than 5% of
              our Common Stock;
       o      each of our directors and executive officers; and
       o      all of our current directors and executive officers as a group.

       Except as otherwise noted below, the address of each person or entity
listed on the table is 1301 North Tustin Avenue, Santa Ana, California 92705.
The address of Dr. Kali Chaudhuri and William E. Thomas is 6800 Indiana Avenue,
Suite 130, Riverside, CA 92506.

                                               BENEFICIAL          PERCENTAGE OF
         NAME                                  OWNERSHIP (1)           TOTAL (2)
- --------------------------------------------------------------------------------
DIRECTORS AND EXECUTIVE OFFICERS
   Ajay G. Meka, M.D.                            166,666 (3)                  *
   Maurice J. DeWald                             283,332 (4)                  *
   Hon. C. Robert Jameson                         50,000 (5)                  *
   Michael Metzler                                50,000 (6)                  *
   Bruce Mogel                                54,903,786 (7)              40.0%
   J. Fernando Niebla                            283,332 (8)                  *
   William E. Thomas                          14,750,000 (9)              10.8%
   Larry B. Anderson                           5,112,000                   3.7%
   Steven R. Blake                                     0                      0
   Daniel J. Brothman                            916,667 (10)                 *
   Milan Mehta                                   229,167 (11)                 *
   Jerry Kanaly                                        0                      0
- --------------------------------------------------------------------------------

All current directors and executive
  officers as a group (11 persons)            66,996,452                   48.9%

PRINCIPAL STOCKHOLDERS (other than
 those named above)
   Orange County Physicians Investment
     Network, LLC                             59,098,430                   43.1%
   Kali P. Chaudhuri, M.D.                    59,772,289 (12)              38.1%
   Healthcare Financial Management
     & Acquisitions, Inc.                    122,680,988 (13)              47.2%
   Medical Provider Financial
     Corporation III                          50,952,381 (14))             27.1%

* Less than 1%

(1) Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or investment
power with respect to securities. Shares of Common Stock subject to options,
warrants and convertible instruments that are exercisable or convertible
currently or within 60 days of October 31, 2007 are deemed outstanding for
computing the percentage of the person holding such option, warrant or
convertible instrument, but are not deemed outstanding for computing the
percentage of any other person. Except as reflected in the footnotes or pursuant
to applicable community property laws, the persons named in the table have sole
voting and investment power with respect to all shares of Common Stock
beneficially owned.


                                       2



(2) Percentages are based on 137,095,716 shares of Common Stock outstanding as
of October 31, 2007, which does not include up to 12,000,000 shares of Common
Stock which may be issued under the Company's 2006 Stock Incentive Plan.

(3) Consists of a portion of a stock option award approved by the Board of
Directors which is exercisable within 60 days of October 31, 2007, pursuant to
the Company's 2006 Stock Incentive Plan. Dr. Meka is a member of Orange County
Physicians Investment Network, LLC ("OC-PIN") and disclaims beneficial ownership
of shares held by OC-PIN except to the extent of his pecuniary interest therein.

(4) Consists of a portion of a stock option award approved by the Board of
Directors which is exercisable within 60 days of October 31, 2007 pursuant to
the Company's 2006 Stock Incentive Plan.

(5) Consists of a portion of a stock option award approved by the Board of
Directors which is exercisable within 60 days of October 31, 2007 pursuant to
the Company's 2006 Stock Incentive Plan.

(6) Consists of a portion of a stock option award approved by the Board of
Directors which is exercisable within 60 days of October 31, 2007 pursuant to
the Company's 2006 Stock Incentive Plan.

(7) Includes shares held by Dr. Kali P. Chaudhuri and William E Thomas, each of
whom has entered into separate irrevocable proxies expiring in July 2009
providing Mr. Mogel with limited voting rights over all of their shares with
respect to certain matters that may be voted on by stockholders. Accordingly,
all shares held by Dr. Kali P. Chaudhuri and William E Thomas are deemed
beneficially owned by Bruce Mogel, although Mr. Mogel has no pecuniary interest
in any such shares.

(8) Consists of a portion of a stock option award approved by the Board of
Directors which is exercisable within 60 days of October 31, 2007 pursuant to
the Company's 2006 Stock Incentive Plan.

(9) Consists of 9,748,498 issued and outstanding shares, 4,951,502 shares which
may be acquired upon exercise of a warrant which expires in July 2008, and a
portion of a stock option award approved by the Board of Directors which is
exercisable within 60 days of October 31, 2007 pursuant to the Company's 2006
Stock Incentive Plan.

(10) Consists of a portion of a stock option award approved by the Board of
Directors which is exercisable within 60 days of October 31, 2007 pursuant to
the Company's 2006 Stock Incentive Plan.

(11) Consists of a portion of a stock option award approved by the Board of
Directors which is exercisable within 60 days of October 31, 2007 pursuant to
the Company's 2006 Stock Incentive Plan.

(12) Consists of 39,789,788 issued and outstanding shares plus 19,982,501 shares
which may be acquired upon exercise of a warrant which expires in July 2008.

(13) Healthcare Financial Management & Acquisitions, Inc., which is affiliated
with the Company's principal lender, Medical Capital Corporation, holds two
warrants to acquire 31.09% and 4.95% of the outstanding shares of Common Stock
of the Company.

(14) Medical Provider Financial Corporation III, which is affiliated with the
Company's principal lender, Medical Capital Corporation, holds a convertible
term note in the principal amount of $10.7 million convertible into Common Stock
of the Company at the rate of $0.21 per share.



                                       3




           PROPOSAL TO AMEND AND RESTATE THE ARTICLES OF INCORPORATION

       On or about October 8, 2007, our Board of Directors approved the
amendment and restatement of the Articles of Incorporation of the Company in the
form attached as Appendix A (the "Amended Articles") for the following purposes:

       o      to increase the Company's authorized shares of Common Stock from
              250,000,000 to 400,000,000 shares;

       o      to provide for the indemnification and exculpation of directors of
              the Company in the Amended Articles as permitted under Nevada law;

       o      to eliminate out-dated or irrelevant provisions in the original
              Articles of Incorporation which were adopted in 1988 by the shell
              company that became Integrated Healthcare Holdings, Inc.,
              including eliminating the names and addresses of the original
              incorporators, registered agent and directors of the Company; and

       o      To consolidate in one document the original Articles of
              Incorporation of the Company and various amendments that have been
              adopted since the original Articles were filed.

       On or about October 8, 2007, the Amended Articles were approved by
written consent of the holders of a majority of the outstanding shares of Common
Stock of the Company. Accordingly, all necessary corporate approvals in
connection with the approval of the Amended Articles have been obtained.

       Our Board of Directors approved the increase in authorized shares of
Common Stock to provide sufficient authorized shares to fulfill our obligations
to issue shares under agreements recently executed by the Company in connection
with the refinancing of our indebtedness with our principal lender and under
equity instruments previously issued by the Company. Under these agreements and
instruments as currently in effect, the Company may be obligated to issue up to
an aggregate of 198,511,582 shares of Common Stock, subject to adjustment as set
forth in these agreements and instruments. Therefore it is necessary to increase
our authorized shares to be able to fulfill our commitments to issue these
additional shares.

       In addition, the Company wishes to be able to take advantage of possible
future financing opportunities and other corporate purposes, as the Board of
Directors determines in its discretion to be in the best interests of the
Company. The additional shares could be used, among other things, for stock
dividends, acquisitions of other companies, public or private financings to
raise additional capital and stock-based employee benefit plans.

       Under the Amended Articles, the newly authorized shares would be
unreserved and available for issuance by the Company without further stockholder
action, except as required by current agreements executed by the Company and
applicable laws and regulations. All of the additional shares resulting from the
proposed increase in our authorized shares of Common Stock would be of the same
class if and when they are issued, and holders would have the same rights and
privileges as holders of shares of Common Stock presently issued and
outstanding, including the same dividend, voting and liquidation rights.

       The holders of our Common Stock generally do not have preemptive rights
to subscribe to additional securities that may be issued by the Company, which
means that current stockholders do not have a prior right to purchase any
additional shares in connection with a new issuance of capital stock of the
Company in order to maintain their proportionate ownership of our Common Stock.
Accordingly, if our Board of Directors elects to issue additional shares of
Common Stock, such issuance could have a dilutive effect on the earnings per
share, voting power and equity ownership of current stockholders.

       The proposed increase in authorized number of shares of Common Stock
could have an anti-takeover effect. The availability for issuance of additional
shares of Common Stock could discourage, or make more difficult, efforts to
obtain control of the Company because such shares could be issued to dilute the
voting power of a person seeking control. For example, it may be possible for
our Board of Directors to delay or impede a merger, tender offer, or proxy
contest that it determines is not in the best interests of the Company and
stockholders by causing such additional authorized shares to be issued to
holders who might side with the board in opposing such a takeover or change in
control. By potentially discouraging unsolicited takeover attempts, the proposed
amendment may limit the opportunity for our stockholders to dispose of their
shares at the higher price generally available in takeover attempts or under a
merger proposal and may also have the effect of permitting our current
management, including the current Board of Directors, to retain its position and
resist changes that stockholders may wish to make if they are dissatisfied with
the conduct of our business.


                                       4



                             ADDITIONAL INFORMATION

       We are subject to the information requirements of the Securities Exchange
Act of 1934, as amended, and in accordance therewith file reports, proxy
statements and other information including annual and quarterly reports on Form
10-K and Form 10-Q with the Securities and Exchange Commission. Reports and
other information filed by us can be inspected and copied at the public
reference facilities maintained at the Securities and Exchange Commission at
Room 1580, 100 F Street, NE, Washington, DC 20549.. Copies of such material can
be obtained upon written request addressed to the Securities and Exchange
Commission, Public Reference Section, at Room 1580, 100 F Street, NE,
Washington, DC 20549, at prescribed rates. The Securities and Exchange
Commission also maintains a web site on the Internet (http://www.sec.gov) where
reports, proxy and information statements and other information regarding
issuers that file electronically with the Securities and Exchange Commission
through the Electronic Data Gathering, Analysis and Retrieval System may be
obtained free of charge.



                                              By Order of the Board of Directors


                                              ----------------------------
                                              Bruce Mogel
                                              Chief Executive Officer


                                       5



                                   APPENDIX A

                              AMENDED AND RESTATED
                            ARTICLES OF INCORPORATION
                                       OF
                      INTEGRATED HEALTHCARE HOLDINGS, INC.

       I, the undersigned Secretary of Integrated Healthcare Holdings, Inc., a
Nevada corporation, do hereby certify that:

       1. The Articles of Incorporation of this Corporation are amended and
restated to read in full as follows:

                                   ARTICLE I
                                NAME AND OFFICES

       Section 1. NAME. The name of the Corporation is Integrated Healthcare
Holdings, Inc.

       Section 2. OFFICES. The Corporation may maintain offices for the
transaction of any business at such places within or outside of the State of
Nevada as it may from time to time determine. Corporate business of every kind
and nature may be conducted, and meetings of directors and stockholders may be
held outside the State of Nevada with the same effect as if held in the State of
Nevada.

                                   ARTICLE II
                                     PURPOSE

       The Corporation is organized for the purpose of engaging in any lawful
act or activity, within or outside of the State of Nevada, for which a
corporation may be organized under the Nevada Revised Statutes other than the
insurance, banking or trust company businesses.

                                  ARTICLE III
                                  CAPITAL STOCK

       Section 1. NUMBER. The aggregate number of shares which the Corporation
shall have authorized is Four Hundred Million (400,000,000) shares of common
stock with par value of $0.001 per share.

       Section 2. CLASSES AND SERIES OF STOCK. The shares of the Corporation are
not to be divided into classes. The Corporation is not authorized to issue
shares in series.

       Section 3. STATED CAPITAL. The sum of the amount of consideration
received by the Corporation for all shares of the Corporation with par value of
$0.001 that have been issued, except such part of the consideration therefor as
may have been allocated to capital surplus in a manner permitted by law, shall
be the stated capital of the Corporation at any particular time.

       Section 4. DIVIDENDS. The holders of the outstanding capital stock shall
be entitled to receive, when and as declared by the Board of Directors, solely
out of the unreserved and unrestricted earned surplus of the Corporation,
dividends payable either in cash, in property, or in shares of the capital stock
of the Corporation.

                                   ARTICLE IV
                         REGULATION OF INTERNAL AFFAIRS

       Section 1. MEETINGS OF STOCKHOLDERS. Meetings of the stockholders of the
Corporation may be held in such place, either within or without the State of
Nevada, as may be provided in the Bylaws. In the absence of any such provision,
all meetings shall be held at the registered office of the Corporation.


                                      A-1



       Section 2. MEETINGS OF DIRECTORS. Meetings of the Board of Directors of
the Corporation, regular or special, may be held either within or without the
State of Nevada.

       Section 3. BYLAWS. The Bylaws of the Corporation shall be adopted by its
Board of Directors. The power to alter, amend or repeal the Bylaws, or to adopt
new Bylaws, shall be vested in the Board of Directors, except that the Board of
Directors may not alter, amend or repeal Bylaws provisions that are specifically
authorized or approved by a vote of the stockholders of the Corporation. The
Bylaws may contain any provision for the regulation and management of the
affairs of the Corporation not inconsistent with the laws of Nevada or these
Articles of Incorporation.

       Section 4. INTEREST OF DIRECTORS IN CONTRACTS. Any contract or other
action between the Corporation and one or more of its directors, or between the
Corporation and any firm of which one or more of its directors are members or
employees, or in which they are interested, or between the Corporation or
association of which one or more of its directors are stockholders, members,
directors, officers, or employees, or in which they are interested, shall be
valid for all purposes, notwithstanding the presence of such director or
directors at the meeting of the Board of Directors of the Corporation which acts
upon, or in reference to, such contract or transaction, and notwithstanding his
or their participation in such action, if the fact of such interest shall be
disclosed or known to the Board of Directors and the Board of Directors, shall,
nevertheless, authorize, approve and ratify such contract or transaction by a
vote of a majority of directors present, such interest of director or directors
to be counted in determining whether a quorum is present, but not to be counted
in calculating the majority necessary to carry such vote. This section shall not
be construed to invalidate any contract or any transaction which would otherwise
be valid under the common and statutory law applicable thereto.

       Section 5. AMENDMENT TO ARTICLE OF INCORPORATION. The Corporation
reserves the right from time to time to amend, alter, or repeal, or to add any
provision to its Articles of Incorporation in the manner prescribed by the laws
of Nevada.

       Section 6. COMPENSATION OF DIRECTORS. The Board of Directors is
authorized to make provision for reasonable compensation to its members when
their services as directors and to fix the basis and conditions upon which this
compensation shall be made. Any director may also serve in the Corporation in
any capacity and receive compensation therefor in any form.

       Section 7. NUMBER OF DIRECTORS. The number of directors of the
Corporation shall be as set forth in the By Laws. Subject to this limitation,
the number of directors may be increased or decreased from time to time by
amendment of the Bylaws, but no decrease shall have the effect of shortening the
term of any incumbent director.

                                   ARTICLE V
                                 INDEMNIFICATION

       Section 1. ELIMINATION OF LIABILITY. To the maximum extent permitted
under the Nevada Revised Statutes, a director or officer of the Corporation
shall not be personally liable to the Corporation or its stockholders for
damages arising as a result of any act or failure to act in his capacity as a
director or officer of the Corporation.

       Section 2. MANDATORY INDEMNIFICATION. The Corporation shall, to the
maximum extent and in the manner permitted by Nevada law, indemnify each of its
directors and officers against expenses (including attorneys fees), judgments,
fines, settlements, and other amounts actually and reasonably incurred in
connection with any proceeding, arising by reason of the fact that such person
is or was an agent of the corporation. For purposes of this paragraph, a
director or officer of the corporation includes any person (i) who is or was a
director or officer of the corporation, (ii) who is or was serving at the
request of the corporation as a director or officer of another corporation,
partnership, joint venture, trust or other enterprise, or (iii) who was a
director or officer of a corporation which was a predecessor corporation of the
corporation or of another enterprise at the request of such predecessor
corporation.

       Section 3. INDEMNIFICATION; MANDATORY PAYMENT OF EXPENSES. The expenses
of officers and directors incurred in defending a civil or criminal action, suit
or proceeding must be paid by the Corporation as they are incurred and in
advance of the final disposition of the action, suit or proceeding, upon and
subject to the receipt by the Corporation of an undertaking by or on behalf of
the director or officer to repay the amount if it is ultimately determined by a
court of competent jurisdiction that he or she is not entitled to be indemnified
by the Corporation.


                                      A-2



       Section 4. EFFECT OF AMENDMENT OR REPEAL. Any amendment to or repeal of
any of the provisions in this Article V shall only be prospective and shall not
adversely affect any right or protection of a director or officer of the
Corporation for or with respect to any act or omission of such director or
officer occurring prior to such amendment or repeal.

                                    * * * * *

       2. The foregoing Amended and Restated Articles of Incorporation have been
duly approved by the Board of Directors.

       3. The foregoing Amended and Restated Articles of Incorporation have been
duly approved by the required vote of stockholders in accordance with sections
78.390 and 78.403 of the Nevada Revised Statutes. The total number of
outstanding shares of Common Stock of the Corporation is ________________, of
which ______________ shares were voted in favor of the Amended and Restated
Articles of Incorporation. The number of shares voting in favor of the amendment
and restatement equaled or exceeded the vote required. The percentage vote
required under applicable law and the Articles of Incorporation in effect at the
time of this amendment was more than fifty percent (50%) of the outstanding
shares of Common Stock.

       EXECUTED this ____ day of ______________, 2007.





                                           ------------------------------

                                           Name: ________________________

                                           Title: Secretary





                                      A-3